Find comprehensive information on Marfan syndrome diagnosis, including clinical features, genetic testing, diagnostic criteria, and ICD-10 code Q87.4. This resource covers differential diagnosis, medical documentation best practices for healthcare professionals, and coding guidelines for accurate billing and reimbursement. Learn about systemic manifestations of Marfan syndrome, cardiovascular complications, and genetic counseling considerations. Explore resources for patients and families seeking support and information on managing Marfan syndrome.
Also known as
Marfan syndrome
Inherited disorder affecting connective tissue.
Mitral valve disorders
Covers various mitral valve problems often seen in Marfan syndrome.
Congenital malformations of eye
Includes eye conditions like lens dislocation associated with Marfan syndrome.
Aortic aneurysm and dissection
Covers aortic complications, a serious risk in Marfan syndrome.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diagnosis Marfan Syndrome confirmed?
When to use each related code
| Description |
|---|
| Connective tissue disorder affecting multiple systems |
| Connective tissue disorder with vascular complications |
| Connective tissue disorder with joint hypermobility |
Coding Marfan syndrome without specific manifestations (e.g., aortic root dilation) leads to lower reimbursement and inaccurate data.
Failing to code all associated manifestations of Marfan syndrome (e.g., mitral valve prolapse, ectopia lentis) undercodes severity and complexity.
Incorrectly coding aortic complications as the primary diagnosis instead of Marfan syndrome can skew quality metrics and impact risk adjustment.
Q: What are the most reliable diagnostic criteria for Marfan Syndrome in adults presenting with equivocal features?
A: Diagnosing Marfan Syndrome (MFS) in adults with equivocal features can be challenging. While the revised Ghent nosology remains the gold standard, its systemic nature necessitates a multidisciplinary approach. Consider implementing a thorough assessment encompassing cardiovascular, ocular, skeletal, and genetic evaluations. Specifically, look for aortic root dilatation (Z-score >= 2), ectopia lentis, and systemic features like pectus excavatum or dural ectasia. Genetic testing for FBN1 mutations plays a crucial role, particularly when clinical findings are ambiguous. Explore how combining clinical findings with genetic testing, family history, and a systemic score can enhance diagnostic accuracy. In complex cases, referral to a specialized Marfan Syndrome clinic may be warranted. Learn more about managing MFS in adults with the latest clinical guidelines.
Q: How do I differentiate between Marfan Syndrome and other connective tissue disorders like Loeys-Dietz syndrome and Ehlers-Danlos syndrome in my clinical practice?
A: Differentiating Marfan Syndrome (MFS) from other connective tissue disorders, such as Loeys-Dietz syndrome (LDS) and Ehlers-Danlos syndrome (EDS), requires careful attention to distinct clinical features. While overlapping symptoms exist, key differences can aid diagnosis. MFS typically involves aortic root aneurysm and ectopia lentis, whereas LDS often presents with arterial tortuosity, bifid uvula/cleft palate, and hypertelorism. EDS subtypes exhibit varying degrees of joint hypermobility, skin hyperextensibility, and tissue fragility, but generally lack the characteristic cardiovascular and ocular findings of MFS. Consider implementing genetic testing as it provides definitive confirmation, particularly for differentiating between these genetically distinct conditions. Explore how a comprehensive family history and detailed physical examination can also guide differential diagnosis. Learn more about the unique management strategies for each connective tissue disorder to tailor patient care effectively.
Patient presents with suspected Marfan syndrome (MFS), a genetic connective tissue disorder. Family history is significant for (positive/negative) Marfan syndrome. Patient exhibits (some/many/all) of the systemic manifestations consistent with this diagnosis, including (list present features, e.g., tall stature, arachnodactyly, pectus excavatum, pectus carinatum, scoliosis, kyphosis, pes planus, joint hypermobility, dolichostenomelia, positive wrist and thumb signs). Cardiovascular findings include (document presence/absence and specifics of aortic root dilation, aortic regurgitation, mitral valve prolapse, mitral regurgitation, aortic dissection). Ocular findings include (document presence/absence and specifics of ectopia lentis, lens subluxation, myopia, retinal detachment). Pulmonary findings include (document presence/absence and specifics of spontaneous pneumothorax, apical blebs). Dural ectasia is (present/absent) based on imaging. Genetic testing for FBN1 gene mutation is (ordered/pending/completed - include results if available). Differential diagnosis includes Loeys-Dietz syndrome, Ehlers-Danlos syndrome, and other connective tissue disorders. Diagnosis of Marfan syndrome is based on Ghent nosology criteria (revised Ghent criteria noted if applicable and specific criteria met documented). Treatment plan includes (cardiology referral, ophthalmology referral, orthopedic referral, genetic counseling, beta-blocker therapy - specify medication and dosage, monitoring for aortic root dilation, surgical intervention if indicated - specify procedure, physical therapy, occupational therapy). Patient education provided regarding Marfan syndrome, including inheritance pattern, potential complications, and importance of regular follow-up. ICD-10 code Q87.4 (Marfan syndrome) is used for billing purposes. Follow-up appointment scheduled in ( timeframe) to monitor disease progression and treatment efficacy.